ViaCyte Funding: $225M Raised, Series D (2015)

ViaCyte funding overview

ViaCyte is based in San Diego, CA. ViaCyte has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in June 2015. The round record for ViaCyte runs through 2015; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures, Adage Capital Partners, Invus Group and 2 others. 8 distinct backers are named across the disclosed rounds.

ViaCyte at a glance

Total raised: $225M
Latest round: Series D
Latest round date: June 2015
Headquarters: San Diego, CA
Notable investors: Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures, Adage Capital Partners, Invus Group, Asymmetry Ventures, Artis Ventures

Frequently asked about ViaCyte funding

How much has ViaCyte raised?: ViaCyte has raised $225M in total disclosed funding across the rounds on record.
Who has invested in ViaCyte?: Bain Capital Life Sciences, TPG Capital, RA Capital Management, Sanderling Ventures, Adage Capital Partners, Invus Group are named among the investors backing ViaCyte.
What was the latest ViaCyte funding round?: The most recent disclosed round is a Series D, announced in June 2015.
Where is ViaCyte based?: ViaCyte is based in San Diego, CA.
When did ViaCyte last raise?: The last disclosed ViaCyte round closed in June 2015 at Series D.

We update the ViaCyte record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.

ViaCyte Funding: $225M Raised, Series D (2015)

ViaCyte funding overview

ViaCyte at a glance

Frequently asked about ViaCyte funding

Companies related to ViaCyte (36)

Browse related funding lists (7)